|
gptkbp:instance_of
|
gptkb:pharmaceuticals
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Taris_Biomedical
gptkb:Actelion
gptkb:Kymab
gptkb:Kenvue
gptkb:Crucell
Zarxio
Acquired Actelion in 2017
|
|
gptkbp:advertising
|
brand partnerships
social media presence
digital marketing strategies
global marketing campaigns
responsible advertising practices
|
|
gptkbp:campaigns
|
gptkb:Care_Inspires_Care
|
|
gptkbp:categories
|
wound care
baby care
over-the-counter pharmaceutical products
skin and hair care
|
|
gptkbp:ceo
|
gptkb:Joaquin_Duato
gptkb:Alex_Gorsky
|
|
gptkbp:community_engagement
|
mental health initiatives
disaster relief efforts
education programs
support for local communities
healthcare access initiatives
|
|
gptkbp:conducts_research_on
|
gptkb:Dr._Paul_Stoffels
|
|
gptkbp:cultural_diversity
|
commitment to workplace diversity
|
|
gptkbp:employees
|
over 130,000
134,000
132,200 (2021)
|
|
gptkbp:focus
|
Pharmaceuticals, Medical Devices, Consumer Health Products
|
|
gptkbp:founded
|
1886
|
|
gptkbp:founded_by
|
gptkb:Robert_Wood_Johnson
gptkb:Edward_Mead_Johnson
gptkb:James_Wood_Johnson
|
|
gptkbp:founded_in
|
1886
|
|
gptkbp:founder
|
gptkb:Robert_Wood_Johnson
Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson
|
|
gptkbp:global_presence
|
over 60 countries
|
|
gptkbp:has_awards
|
numerous industry awards
|
|
gptkbp:has_mission
|
to improve the health of people
|
|
gptkbp:head_of_consumer_health
|
Thibaut Mongon
|
|
gptkbp:head_of_medical_devices
|
gptkb:Ashley_Mc_Evoy
|
|
gptkbp:head_of_pharmaceuticals
|
gptkb:Mathai_Mammen
|
|
gptkbp:headcount
|
132,200 (2021)
|
|
gptkbp:headquarters
|
gptkb:New_Brunswick,_New_Jersey
New Brunswick, New Jersey, USA
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Johnson & Johnson
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
gptkb:medical_devices
consumer health
consumer health products
|
|
gptkbp:is_involved_in
|
research and development
clinical trials
|
|
gptkbp:is_known_for
|
gptkb:Philanthropy
innovation in healthcare
safety and quality standards
|
|
gptkbp:is_vulnerable_to
|
gptkb:Janssen_COVID-19_Vaccine
|
|
gptkbp:market_cap
|
450 billion USD (2021)
approximately 440 billion USD (2021)
|
|
gptkbp:notable_products
|
gptkb:Xarelto
gptkb:Stelara
gptkb:Aveeno
gptkb:Neutrogena
gptkb:Remicade
gptkb:Tylenol
gptkb:Acuvue
gptkb:Listerine
gptkb:Band-Aid
gptkb:Ortho_Tri-Cyclen
gptkb:Imbruvica
gptkb:vaccine
gptkb:sunglasses
Vaccines
Surgical instruments
Surgical sutures
Johnson's Baby Shampoo
|
|
gptkbp:operates_in
|
over 60 countries
global market
|
|
gptkbp:parent_company
|
gptkb:Johnson_&_Johnson_Family_of_Companies
|
|
gptkbp:partnership
|
gptkb:Global_Fund
gptkb:World_Health_Organization
gptkb:Gavi,_the_Vaccine_Alliance
gptkb:UNICEF
Partnership with various healthcare organizations
|
|
gptkbp:philanthropy
|
gptkb:Johnson_&_Johnson_Foundation
|
|
gptkbp:product
|
gptkb:Xarelto
gptkb:Stelara
gptkb:Aveeno
gptkb:Neutrogena
gptkb:Remicade
gptkb:Tylenol
gptkb:Listerine
gptkb:Band-Aid
gptkb:Ortho_Clinical_Diagnostics
gptkb:Ortho_Tri-Cyclen
gptkb:Imbruvica
gptkb:vaccine
gptkb:sunglasses
gptkb:Johnson's_Baby
Vaccines
Surgical sutures
Surgical products
Orthopedic implants
|
|
gptkbp:products
|
gptkb:pharmaceuticals
gptkb:Aveeno
gptkb:Neutrogena
gptkb:Tylenol
gptkb:Acuvue
gptkb:Band-Aid
gptkb:Johnson's_Baby
gptkb:medical_devices
consumer health products
|
|
gptkbp:rank
|
among the largest healthcare companies
|
|
gptkbp:research_and_development
|
gptkb:vaccine
over 12 billion USD (2021)
HIV vaccine
Cancer treatments
Cardiovascular products
Orthopedic products
|
|
gptkbp:revenue
|
93.77 billion USD (2021)
93.77 billion USD (2020)
over $93 billion
|
|
gptkbp:service_area
|
Worldwide
|
|
gptkbp:stock_exchange
|
gptkb:NYSE
on the New York Stock Exchange
|
|
gptkbp:stock_symbol
|
gptkb:JNJ
|
|
gptkbp:subsidiary
|
gptkb:De_Puy_Synthes
gptkb:Ethicon
gptkb:Janssen_Pharmaceuticals
|
|
gptkbp:sustainability
|
sustainable business practices
Health for Humanity 2025 Goals
|
|
gptkbp:sustainability_efforts
|
responsible sourcing of materials
zero waste to landfill by 2025
reduce carbon footprint by 80% by 2030
reduce water usage by 20% by 2030
|
|
gptkbp:sustainability_initiatives
|
gptkb:healthcare_access
diversity and inclusion
community impact
Diversity and inclusion programs
Waste reduction programs
Responsible sourcing
Climate change initiatives
environmental health
Environmental sustainability goals
Water stewardship programs
Employee engagement in sustainability
Community impact programs
Health for Humanity
|
|
gptkbp:trade
|
NYSE: JNJ
|
|
gptkbp:traded_on
|
gptkb:New_York_Stock_Exchange
gptkb:NYSE
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:vision
|
to be the world’s healthiest workforce
|
|
gptkbp:website
|
www.jnj.com
|
|
gptkbp:year_established
|
1886
|
|
gptkbp:bfsParent
|
gptkb:W3_C
gptkb:Bill_Gates
|
|
gptkbp:bfsLayer
|
3
|